Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Clinical trial NCT04944979 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04944979
Sponsor: Kedrion S.p.A.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Disease

Start date: 2021-03-31
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.